Browse studies

Find your next paid study

5 recruiting studies matching your filters

TIER-PALLIATIVE CARE: A Population-based Care Delivery Model to Match Evolving Patient Needs and Palliative Care Services for Community-based Patients With Heart Failure or Cancer

TIER-PC is an adaptive model of delivering palliative care that provides the right level of care to the right patients at the right time. It represents an adap…

Advanced Heart FailureAdvanced Non-Colorectal Gastrointestinal CancerAdvanced Lung Cancer+1 more

Estimated

~$10 – $6,250

Icahn School of Medicine at Mount SinaiNCT07391956

Observational

TIER-PALLIATIVE CARE: A Population-based Care Delivery Model to Match Evolving Patient Needs and Palliative Care Services for Community-based Patients With Heart Failure or Cancer

TIER-PC is an adaptive model of delivering palliative care that provides the right level of care to the right patients at the right time. It represents an adap…

Advanced Heart FailureAdvanced Non-Colorectal Gastointestinal CancerAdvanced Lung Cancer

Estimated

~$10 – $6,250

Icahn School of Medicine at Mount SinaiNCT06228209

Phase 1

A Phase I/IIa, Open-Label, Dose Escalation Study to Evaluate the Safety and Tolerability of HiCM-188, an Allogeneic iPSC-derived Cardiomyocyte Therapy, in Adult Patients With Advanced Heart Failure

This clinical study will evaluate the safety and tolerability of HiCM-188, an investigational allogeneic induced pluripotent stem cell (iPSC)-derived cardiomyo…

Advanced Heart FailureIschemic Heart Failure

Estimated

~$10 – $8,750

HELP Therapeutics Co., Ltd.NCT07646210

Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool

There are a variety of educational documents available to help in a participant's decision for VAD implant, however there is little information available to po…

Ventricular Assist DeviceAdvanced Heart FailureAnticipatory Guidance

Estimated

~$10 – $1,125

Bryan HeartNCT06823583

Observational

The PALL-VAD Study: Palliative Care Intervention to Improve Health Related Quality of Life for Patients With Heart Failure on Long-Term LVAD Support: A Pilot, Prospective, Randomized Trial

Background: While left ventricular assist device (LVAD) therapy improves survival in patients with advanced heart failure (AHF), unique LVAD-related burdens ma…

Advanced Heart FailureMechanical Circulatory SupportLeft Ventricular Assist Device+1 more

Estimated

~$10 – $7,500

Medstar Health Research InstituteNCT07445932